Alunbrig Tablets 90mg (Brigatinib), manufactured by Takeda Pharmaceutical (YJ code: 4291069F2029, standard: 90mg 1 tablet), is a kinase inhibitor used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC) by targeting abnormal ALK and EGFR proteins to inhibit cancer cell growth.
Alunbrig Tablets 90mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
